URSODESOXYCHOLIC ACID MYLAN 500 mg dry tablet,,,URSODESOXYCHOLIC ACID 500 mg tab (URSODESOXYCHOLIC ACID MYLAN)

DELURSAN 500 mg tab dry film

pharmacotherapeutic classification:

Gastro-Entero-Hepatology : Primary biliary cirrhosis ( Ursodeoxycholic acid )
Metabolism - Diabetes - Nutrition - Mucoviscidosis : Liver damage: ursodeoxycholic acid ( Cholelithiasis: bile acid )

ATC classification:

DIGESTIVE TRACT AND METABOLISM : HEPATIC AND BILIARY THERAPY - BILIARY THERAPY : BILE ACIDS AND DERIVATIVES ( URSODESOXYCHOLIC ACID )

Substance
ursodeoxycholic acid

Excipients:

corn starch , colloidal anhydrous silica , povidone , sodium lauryl sulfate , magnesium stearate

film coating:  hypromellose , propylene glycol

colorant (film coating):  titanium dioxide

Excipients with known effect :

NTE without threshold dose:  anhydrous glucose

Presentation

URSODESOXYCHOLIC ACID MYLAN 500 mg Cpr dry pell Plq/60

Cip: 3400930203736

Storage conditions: Before opening: for 36 months

List 1

Approved for Communities

Refund: 65%